FHTX Latest Press Releases

-- June 5, 2026 --

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 Globe Newswire 7:00 AM

-- May 12, 2026 --

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May Globe Newswire 7:00 AM

-- May 7, 2026 --

Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update Globe Newswire 7:00 AM

-- April 21, 2026 --

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting Globe Newswire 4:05 PM

-- April 9, 2026 --

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting Globe Newswire 7:00 AM

-- March 11, 2026 --

Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook Globe Newswire 4:09 PM

-- February 24, 2026 --

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences Globe Newswire 7:00 AM

-- February 23, 2026 --

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer Globe Newswire 7:00 AM

-- February 3, 2026 --

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software